We have previously established that isoprenylation of the prostacyclin receptor (IP) is required for its efficient G-protein coupling and effector signalling (Hayes et al., (1999) J. Biol. Chem. 274, 23707-23718). In the present study, we sought to investigate whether the IP may actually be subject to palmitoylation in addition to isoprenylation and to establish the functional significance thereof. The human (h) IP was efficiently palmitoylated at Cys 308 and Cys 311
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Abstract.
We have previously established that isoprenylation of the prostacyclin receptor (IP) is required for its efficient G-protein coupling and effector signalling (Hayes et al., (1999) J. Biol. Chem. 274, 23707-23718). In the present study, we sought to investigate whether the IP may actually be subject to palmitoylation in addition to isoprenylation and to establish the functional significance thereof. The human (h) IP was efficiently palmitoylated at Cys 308 HEK.hIP SSLC cells stably over-expressing the wild type hIP and the isoprenylation defective hIP SSLC have been previously described (20, 26) . The plasmids pCMV-Gα q , pCMV-Gα s and pHM:Ha-ras have been previously described (18, 20, 26, 25) . HEK 293 cells were transfected with pADVA (10 µg /10cm-dish) and pCMV-or pHM-based vectors (25 µg /10-cm dish) using the calcium phosphate/DNA co-precipitation procedure (27 , pHM-hIP C309,311S or pHM-hIP C308,309,311S (25 µg /10-cm dish), respectively, using the calcium phosphate/DNA co-precipitation procedure (27) . For the generation of stable cell lines, forty eight hr post transfection, G418 (0.8 mg/ml) selection was applied and after approximately 21 days, G418 resistant colonies were selected and individual clonal stable cell isolates were examined for IP expression by radioligand binding. mM Tris-HCl. pH 6.8; 100 µl) and boiled for 5 min. Samples were then resolved by SDS-8 plus pADVA (10 µg/10-cm dish) or non-transfected HEK 293 cells were plated to achieve a density of approximately 3 x 10 6 cells/10 cm dish (approx 80 % confluency) on the day of metabolic labelling. Cells were washed once with PBS and were then metabolically labelled in serum free-MEM (1.5 ml) containing 1.5 mCi of [ 3 H]palmitic acid (60 Ci/mmol), in the presence of IP agonist cicaprost (1 µM) . Following incubation at 37 o C for 2 hr, cells were lysed by the addition of 600 µl RIPA buffer (20 mM Tris-Cl, pH 8.0, 0.15 M NaCl, 1 % Triton X-100, 0.1 % SDS, 1 % deoxycholate, 10 mM EDTA, pH 8.0, 1 mM PMSF, 2 mM 1, 10-phenanthroline, 10 µg/ml aprotinin, 10 µg/ml antipain, 1 µg/ml leupeptin, 10 µg/ml benzamidine). Cells were then harvested followed by disruption of the lysate by passing through needles of decreasing bore size (G23, G26). Cell lysates were then subjected to centrifugation at 14, 000 x g for 5 min. The supernatant (600 µg) was subjected to immunoprecipitation using the anti-HA 101r antibody
Western-blot analysis
(1/300) as previously described (29 were determined and expressed, in arbitrary units of intensity, relative to basal levels. Thereafter, following fluorographic exposure, PVDF membranes were screened by immunoblot analysis using the anti-HA 3F10 peroxidase conjugate antibody (1 : 1000) followed by chemiluminescence detection.
Radioligand Binding Studies.
For membrane preparation, cells were harvested by centrifugation at 500 x g at 4 °C for 5 min followed by washing three times with phosphate-buffered saline (PBS). Cells were then resuspended in Homogenization Buffer (25 mM Tris-HCl, pH 7.5, 0.25 M sucrose, 10 mM MgCl 2 , 9 10 mM MnCl 2 , 1 mM EDTA, 10 mM indomethacin). IP radioligand binding assays were carried out at 4 ºC for 1 h, using 100 µg of whole cell protein in 100 µl reactions in the presence of 4 nM Protein determinations were carried out using the Bradford assay (32).
Measurement of cAMP.
cAMP assays were carried out as previously described (18 were transiently co-transfected with pCMV-Gα s (25 µg/10-cm dish) plus pADVA (10 µg/10-cm dish) and were harvested and assayed 48 hr post-transfection. To investigate the effect of lovastatin on cicaprost-induced cAMP generation, cells were pre-incubated with 10 µM lovastatin for 16 hr prior to harvesting for cAMP assays.
In each case, cAMP reactions were terminated by heat inactivation at 100 °C for 5 min and the level of cAMP produced was quantified using the cAMP binding protein assay (33) .
Levels of cAMP produced by ligand-treated cells over basal stimulation, determined in the presence of HBS, were expressed as fold stimulation relative to basal (fold increase ± S.E.M.).
Measurement of IP 3 levels.
Intracellular IP 3 levels were measured as previously described (29). Briefly, cells were transiently co-transfected with either pCMV-Gα q (25 µg/10-cm dish) plus pADVA (10 µg/10-cm dish) or, as controls, with the vector pCMV5 (25 µg/10-cm dish) plus pADVA (10 µg/10-cm dish). After 48 hr, cells were harvested, washed twice in ice-cold PBS and were then resuspended at approximately 5 x 10 6 cells/ml in HBS containing 10 mM LiCl. Cells (200 µl) were then preincubated at 37 °C for 10 min. Thereafter, cells were stimulated for 2 min at 37 °C in the presence ] i ± S.E.M.; n = 4).
Data analyses
Statistical analysis was carried out using the unpaired Student's t test using GraphPad Prism V2.0 programme (GraphPad Software Inc., San Diego, CA, U.S.A). P-values of less than or equal to 0.05 were considered to indicate a statistically significant difference. Amino acid sequence alignments were carried out using the Clustal W software (34) where sequences were aligned to show maximum homology.
Results.
The role of C-tail sequences in signalling by the hIP.
Previous studies have demonstrated that isoprenylation of the IP within its C-tail region is required for its efficient intracellular signalling (18, 25 Figure 1A ) and, at concentrations less than 10 -7 M, were not significantly different than those generated by control HEK 293 cells (25). Moreover, stimulation of hIP Figure 1B ) and IP 3 generation (data not shown) were significantly reduced relative to both the wild hIP and the hIP ∆312 and, consistent with our previous reports (25), were not substantially greater than those generated by HEK 293 cells. While co-transfection of Gα q significantly augmented cicaprost-induced IP 3 generation by both the hIP (p < 0.05) and the hIP ∆312 (p < 0.05), it did not enhance IP 3 generation by the hIP SSLC ( Figure 1D ); Western blot analysis confirmed over-expression of Gα q ( Figure 1E ). Figure 3B ; p < 0.11). Over-expression of Gα s in HEK.hIP ∆307 cells was confirmed by western blot analysis ( Figure 3C ).
Thereafter, the ability of hIP ∆307 to couple to Gα q and to PLC activation was investigated. Palmitoylation of both the isoprenylation defective hIP SSLC and hIP ∆312 was also observed ( Figure 5C , lane 2 & 3, respectively). However, while the hIP ∆312 was palmitoylated to levels comparable to that of the wild type hIP, the level of palmitoylation of the hIP SSLC appeared to be somewhat reduced (2.28 and 1.44-fold increase in palmitoylation relative to basal levels observed in HEK 293 cells, respectively). In contrast, palmitoylation of hIP ∆307 was not detected ( Figure   5C , lane 4). In order to confirm the identities of the palmitoylated proteins to be those of the hIP and its variants and to ascertain whether failure to detect palmitoylation of the hIP ∆307 was not due altered expression levels, following fluorographic exposure the PVDF membranes were screened with anti-HA 3F10 peroxidase conjugated antibody ( Figure 5D ). In each case, similar to that observed in the palmitoylation assays ( Figure 5C ) ] i mobilization to levels that were not significantly different from those generated by the hIP ( Figure 8C ; p = 0.68). However, levels of Figure 10A ; p > 0.05). On the other hand, levels of cAMP generation by hIP C308,311S and hIP C308,309,311S were significantly lower than those levels generated by the hIP throughout the range of cicaprost concentrations examined ( Figure 10A ; p < 0.05) and, in fact,
Levels of cicaprost-induced [Ca
were not significantly different from those levels generated by the hIP SSLC (p > 0.88; 25) or the hIP ∆307 cells (p > 0.18; Figure 3A ). Moreover, co-transfection of cells with Gα s significantly augmented cAMP generation by the hIP C311S and the hIP C309,311S to levels comparable to the hIP ( Figure 10B ) but failed to significantly augment cAMP generation by hIP C308,311S or by the cells with lovastatin significantly impaired cicaprost-induced cAMP generation confirming that the hIP C308S
, hIP C311S and hIP C308,311S are indeed subject to protein isoprenylation ( ] i mobilization to levels that were not significantly different from those generated by the hIP ( Figure 10C Discussion:
In the current study, through a combination of deletion and site-directed mutagenesis, in vivo metabolic labelling studies and through the use of pharmacologic inhibitors of protein isoprenylation, we investigated the requirement for palmitoylation and isoprenylation for IP function and intracellular signalling. To this end, we initially compared signalling by the wild type hIP, the isoprenylation defective hIP SSLC and the deletion mutant hIP ∆312 . Similar to the hIP, the hIP While palmitoylation of the hIP was not required for its ligand binding ( ) signalling.
A number of independent studies have demonstrated that impairment of receptor palmitoylation, such as in the case of the CCR5 receptor, may result in accumulation of GPCRs in intracellular stores and in the lowering of cell surface receptor expression (39) . In the present study, for the hIP and its various mutant forms, we have established that all stable cell lines under study express equivalent cell surface receptor numbers, thereby confirming that neither palmitoylation nor, indeed, isoprenylation per se alter the ability of the hIP to reach the plasma membrane. Thus, differences in IP signalling by the palmitoylation defective mutants may not be attributed to altered/reduced cell surface receptor expression, but rather is most likely due to direct alteration in their palmitoylation status. While our metabolic labelling studies clearly demonstrate that the hIP is palmitoylated at Cys 308 and Cys 311 , and our intracellular signalling studies have highlighted the importance of those palmitoyl moieties in facilitating G protein coupling/effector signalling, in the absence of an appropriate pharmacologic inhibitor of palmitoylation, our studies cannot exclude the possibility that it is the presence of Cys residues at those sites, as opposed to the palmitoyl-Cys residues, that are critical in mediating that signalling.
Thus, through our previous studies (18, 26, 25) and those outlined in the present study involving the hIP, it is evident that the IP is certainly unique among GPCRs thus far characterised in that it is isoprenylated and palmitoylated and together these dual lipidations modulate IP coupling to G s -and G q -regulated effector systems, but do not affect agonist binding. In attempting to put forward a model (Figure 11 ) to describe the relative involvements of isoprenylation and palmitoylation in regulating IP signalling, we have drawn from the prototypic Ha-Ras in assuming that isoprenylation precedes palmitoylation (14) and that both types of lipid modifications mediate protein-membrane, rather than protein-protein interactions. However, we preface our model by stating that this may not strictly be accurate as in the case of the hIP SSLC , for example, palmitoylation occurs in the absence of isoprenylation, and further experiments are required to precisely define or identify the nature of the individual lipid interactants. However, despite these limitations, we now propose a model, as outlined in Figure 11 , to explain the role of isoprenylation and palmitoylation in mediating hIP coupling to G s /adenylyl cyclase and G q /PLC effector signalling. Additionally, through this model, outlined below, we propose to explain the apparent paradox as to why the hIP ∆312 , but not the hIP SSLC , mediates efficient signalling to both G s /adenylyl cyclase and G q /PLC effector systems.
In this model (Figure 11 ), we propose that the newly translated hIP undergoes isoprenylation through attachment of a farnesyl isoprenoid to Cys 383 within its "CAAX motif".
Insertion of the farnesyl group into the lipid bilayer results in the formation of a fourth intracellular loop (IC4 While recognizing that the IP is somewhat unparalleled among well characterised GPCRs, the proposed double loop A and loop B structure within the C-tail domain of the hIP is not unlike that which has recently been proposed to occur for the 5-hydroxytryptamine (4A) (5-HT 4(a) )
receptor (40) . In their study, Ponimaskin et al., (40) established that, like many other GPCRs, the The finding that modulation of the palmitoylation status of the hIP significantly affects its G protein coupling characteristics is indeed consistent with data generated for several GPCRs including rhodopsin, the β 2 AR, as well as for the endothelin (ET) A and ET B receptors (7, 9, 41) .
Functional characterization of the non-palmitoylated β 2 AR and the ET B receptor revealed that palmitoylation is essential for agonist-stimulated coupling to G s and to both G q and G i proteins, respectively (9, 41). However, analysis of the non-palmitoylated ET A receptor mutant revealed that agonist-mediated G s coupling was unaffected whereas signalling through G q was abolished (42) . Similar to that of the ET A receptor, we have established that mutation of Cys 308 significantly impaired hIP C308S coupling to Gα q -, but not to Gα s -, regulated effector signalling providing further evidence that palmitoylation may differentially regulate distinct signal transduction pathways.
As stated, various studies have indeed indicated that the functional implications of palmitoylation is both individual / specific to the given GPCR and may also be diverse (3, 2, 1).
While agonist-stimulation has been reported to enhance palmitoylation of the β 2 AR (10) and of the ) and, as positive controls HEK.hIP Cells were pre-incubated with 10 µM lovastatin (+) or with its vehicle (-) for 16 hr prior to harvesting for cAMP assays, in response to stimulation with 1 µM cicaprost. In each case, basal cAMP levels were determined by exposing the cells to the vehicle HBS under identical incubation conditions. Levels of cAMP produced in ligand-stimulated cells relative to basal cAMP levels were expressed as fold stimulation of basal (fold increase in cAMP ± S.E.M., n = 3). P values indicate statistical comparisons of the effect of lovastatin on cicaprost-induced cAMP generation. 
